Overview: Cell-based models of Parkinson's disease

D. James Surmeier*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


This chapter presents an overview of cell-based models and pathogenic mechanisms in Parkinson's disease (PD). The cell-based models are particularly valuable in tracking the consequences of toxin exposure and genetic mutations in a cellular environment. The advantage of cell lines is ease of generation, phenotypic homogeneity transfectability, and accessibility to pharmacological manipulation as well as physiological and anatomical analysis. The utility of cell-based models in the pursuit of genetic mechanisms in PD is perhaps stronger, as the basic function of most of the proteins encoded by these genes is being explored. The role of interacting proteins and aging in determining the functional consequences of mutations linked to PD is analyzed. A summary of work with primary cultures of mesencephalic dopaminergic neurons examining the cascade of events triggered by mitochondrial toxins is presented. It is found that fox2a haploinsufficiency leads to a late onset degeneration of mesencephalic dopaminergic neurons and a Parkinsonian phenotype.

Original languageEnglish (US)
Title of host publicationParkinson's Disease
PublisherElsevier Inc
Number of pages6
ISBN (Print)9780123740281
StatePublished - 2008

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Overview: Cell-based models of Parkinson's disease'. Together they form a unique fingerprint.

Cite this